Convergence Pharmaceuticals' Corporate Minority Round

Convergence Pharmaceuticals raised a round of funding on October 06, 2010. Investors include GlaxoSmithKline.

Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect pro…

Articles about Convergence Pharmaceuticals' Corporate Minority Round: